🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

Insiders Buying Blackstone, STAAR Surgical And 2 Other Stocks

Published 25/09/2023, 13:01
© Reuters.  Insiders Buying Blackstone, STAAR Surgical And 2 Other Stocks
BX
-
STAA
-
MEI
-
H
-

Benzinga - by Lisa Levin, Benzinga Editor.

Although U.S. stocks closed lower on Friday, there were a few notable insider trades.

When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.

Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform.

STAAR Surgical

  • The Trade: STAAR Surgical Company (NASDAQ: STAA) Director Dr. Elizabeth Yeu acquired a total of 2,500 shares an average price of $40.00. To acquire these shares, it cost around $100,000.
  • What’s Happening: Stifel maintained Staar Surgical with a Hold and lowered the price target from $45 to $40.
  • What STAAR Surgical Does: Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye.
Blackstone
  • The Trade: Blackstone Inc. (NYSE: BX) Director Reginald Brown acquired a total of 1,842 shares at an average price of $111.24. To acquire these shares, it cost around $204,904.
  • What’s Happening: Blackstone reported weaker-than-expected sales results for its second quarter.
  • What Blackstone Does: Blackstone is one of the world's largest alternative asset managers with $991.3 billion in total asset under management, including $732.0 billion in fee-earning asset under management, at the end of March 2023.
Don’t forget to check out our premarket coverage here

Hyatt Hotels

  • The Trade: Hyatt Hotels Corporation (NYSE: H) Director Richard Tuttle bought a total of 1,250 shares at an average price of $104.49. To acquire these shares, it cost around $130,615.
  • What’s Happening: Stifel reiterated a Hold rating on Hyatt Hotels, lowering the price target to $115 from $119.
  • What Hyatt Hotels Does: Hyatt is an operator of owned (4% of total rooms) and managed and franchise (96%) properties across around 20 upscale luxury brands, which includes vacation brands (Apple Leisure Group, Hyatt Ziva and Hyatt Zilara), the recently launched full-service lifestyle brand Hyatt Centric, the soft lifestyle brand Unbound, and the wellness brand Miraval.
Check This Out: Thor Industries Likely To Report Lower Q4 Earnings; Here's A Look At Recent Price Target Changes By The Most Accurate Analysts

Methode Electronics

  • The Trade: Methode Electronics, Inc. (NYSE: MEI) Director Walter J Aspatore bought a total of 1,000 shares at an average price of $22.50. The insider spent around $22,500 to buy those shares.
  • What’s Happening: Methode Electronics reported a first-quarter FY24 net sales growth of 2.6% year-on-year to $289.7 million, beating the consensus of $287.75 million.
  • What Methode Electronics Does: Methode Electronics Inc makes component and subsystem devices employing electrical, radio remote control, electronic, wireless, and sensing technologies.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.